TAK

Takeda Pharmaceutical Company Limited

Healthcare›Drug Manufacturers - Specialty & Generic|New York Stock Exchange|JP

Price

$18.74

Market Cap

$59.20B

Beta

0.10

P/E

0.5

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-2.03%

EPS Growth (YoY)-45.20%

Revenue CAGR 3Y+4.38%

P/E Ratio0.5

PEG Ratio—

FCF Yield+1615.78%

Debt / Equity0.64

Interest Coverage1.2x

No credit card required

Already have an account? Sign in to view the full analysis for TAK.